The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's current EPS (TTM) is C$18.18. In 2024 the company made an earnings per share (EPS) of C$10.63 a decrease over its 2023 EPS that were of C$17.52.